Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Aug;72(2):667–676. doi: 10.1172/JCI111016

Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism

M F Attie 1,2,3, J R Gill Jr 1,2,3, J L Stock 1,2,3, A M Spiegel 1,2,3, R W Downs Jr 1,2,3, M A Levine 1,2,3, S J Marx 1,2,3
PMCID: PMC1129226  PMID: 6874959

Abstract

Familial hypocalciuric hypercalcemia (FHH) is an autosomal dominant trait comprising hypercalcemia, hypophosphatemia, parathyroid hyperplasia, and unusually low renal clearance of calcium. We evaluated the role of parathyroid hormone in the relative hypocalciuria of FHH and characterized the renal transport of calcium in this disorder using three previously hypercalcemic FHH patients with surgical hypoparathyroidism and three controls with surgical hypoparathyroidism. Intravenous infusion of calcium chloride in two patients with FHH and in three controls increased serum calcium from a mean basal of 5.0 to a mean peak of 6.8 meq/liter in two FHH patients and from 4.2 to 5.7 in three control subjects. Urinary calcium in a third FHH patient was studied without calcium infusion during recovery from hypercalcemia of vitamin D intoxication. At all serum concentrations of calcium, calcium clearance was lower in FHH than in controls; at base-line serum calcium, the ratio of calcium clearance to inulin clearance (CCa/CIN) in FHH subjects was 32% of that in controls and decreased to 19% during hypercalcemia. Calcium infusion increased the ratio of sodium clearance to inulin clearance in controls from a base line of 0.020 to 0.053 at peak concentrations of calcium in serum, but did not affect this parameter in FHH (0.017 at base-line serum calcium vs. 0.019 at peak).

When calcium infusion studies were performed (in two patients with FHH and one control) during administration of acetazolamide, a drug whose principal renal action causes inhibition of proximal transport of solute, CCa/CIN in the patients with FHH was 29 and 7% of that of the control at base-line and peak serum calcium, respectively. In contrast, ethacrynic acid, a diuretic that acts in the ascending limb of the loop of Henle, increased CCa/CIN more in the FHH patients than in the control subject; CCa/CIN was 65% at base-line and 47% at peak serum calcium, compared with that of the control subject. The greater calciuric response to ethacrynic acid than to acetazolamide or calcium infusion alone in FHH indicates that a major renal locus of abnormal calcium transport in this disorder may be the ascending limb of the loop of Henle.

Decreased clearance of calcium in patients with FHH and hypoparathyroidism when compared with hypoparathyroid controls indicates that relative hypocalciuria in FHH is not dependent on hyperparathyroidism. Since the parathyroid glands in FHH are not appropriately suppressed by calcium, this implies that FHH represents a disorder of abnormal transport of, and/or response to, extracellular calcium in at least two organs, parathyroid gland and kidney.

Full text

PDF
676

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck L. H., Goldberg M. Effects of acetazolamide and parathyroidectomy on renal transport of sodium, calcium, and phosphate. Am J Physiol. 1973 May;224(5):1136–1142. doi: 10.1152/ajplegacy.1973.224.5.1136. [DOI] [PubMed] [Google Scholar]
  2. Besarab A., Swanson J. W. Differences in effects of amino-terminal and intact parathyroid hormone on calcium, phosphate, and cAMP excretion by the isolated perfused rat kidney. Ren Physiol. 1982;5(6):261–271. doi: 10.1159/000172866. [DOI] [PubMed] [Google Scholar]
  3. Bethune J. E., Turpin R. A., Inoue H. Effect of parathyroid hormone extract on divalent ion excretion in man. J Clin Endocrinol Metab. 1968 May;28(5):673–678. doi: 10.1210/jcem-28-5-673. [DOI] [PubMed] [Google Scholar]
  4. Bijvoet O. L., van der Sluys Veer J., de Vries H. R., van Koppen A. T. Natriuretic effect of calcitonin in man. N Engl J Med. 1971 Apr 1;284(13):681–688. doi: 10.1056/NEJM197104012841301. [DOI] [PubMed] [Google Scholar]
  5. Broadus A. E., Mahaffey J. E., Bartter F. C., Neer R. M. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test. J Clin Invest. 1977 Oct;60(4):771–783. doi: 10.1172/JCI108831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brown E. M., Aurbach G. D. Role of cyclic nucleotides in secretory mechanisms and actions of parathyroid hormone and calcitonin. Vitam Horm. 1980;38:205–256. doi: 10.1016/s0083-6729(08)60486-0. [DOI] [PubMed] [Google Scholar]
  7. Coburn J. W., Hartenbower D. L., Massry S. G. Modification of calciuretic effect of extracellular volume expansion by phosphate infusion. Am J Physiol. 1971 Feb;220(2):377–383. doi: 10.1152/ajplegacy.1971.220.2.377. [DOI] [PubMed] [Google Scholar]
  8. Eknoyan G., Suki W. N., Martinez-Maldonado M. Effect of diuretics on urinary excretion of phosphate, calcium, and magnesium in thyroparathyroidectomized dogs. J Lab Clin Med. 1970 Aug;76(2):257–266. [PubMed] [Google Scholar]
  9. Foley T. P., Jr, Harrison H. C., Arnaud C. D., Harrison H. E. Familial benign hypercalcemia. J Pediatr. 1972 Dec;81(6):1060–1067. doi: 10.1016/s0022-3476(72)80232-4. [DOI] [PubMed] [Google Scholar]
  10. Gill J. R., Jr, Bell N. H., Bartter F. C. Effect of parathyroid extract on magnesium excretion in man. J Appl Physiol. 1967 Jan;22(1):136–138. doi: 10.1152/jappl.1967.22.1.136. [DOI] [PubMed] [Google Scholar]
  11. Heath H., 3rd, Purnell D. C. Urinary cyclic 3',5'-adenosine monophosphate responses to exogenous and endogenous parathyroid hormone in familial benign hypercalcemia and primary hyperparathyroidism. J Lab Clin Med. 1980 Dec;96(6):974–984. [PubMed] [Google Scholar]
  12. KLEEMAN C. R., BERNSTEIN D., ROCKNEY R., DOWLING J. T., MAXWELL M. H. Studies on the renal clearance of diffusible calcium and the role of the parathyroid glands in its regulation. Yale J Biol Med. 1961 Aug;34:1–30. [PMC free article] [PubMed] [Google Scholar]
  13. King R. G., Stanbury S. W. Magnesium metabolism in primary hyperparathyroidism. Clin Sci. 1970 Aug;39(2):281–303. doi: 10.1042/cs0390281. [DOI] [PubMed] [Google Scholar]
  14. Lemann J., Litzow J. R., Lennon E. J. Studies of the mechanism by which chronic metabolic acidosis augments urinary calcium excretion in man. J Clin Invest. 1967 Aug;46(8):1318–1328. doi: 10.1172/JCI105624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lotz M., Zisman E., Bartter F. C. Evidence for a phosphorus-depletion syndrome in man. N Engl J Med. 1968 Feb 22;278(8):409–415. doi: 10.1056/NEJM196802222780802. [DOI] [PubMed] [Google Scholar]
  16. Marx S. J., Attie M. F., Levine M. A., Spiegel A. M., Downs R. W., Jr, Lasker R. D. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 1981 Nov;60(6):397–412. doi: 10.1097/00005792-198111000-00002. [DOI] [PubMed] [Google Scholar]
  17. Marx S. J., Attie M. F., Spiegel A. M., Levine M. A., Lasker R. D., Fox M. An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds. N Engl J Med. 1982 Feb 4;306(5):257–264. doi: 10.1056/NEJM198202043060502. [DOI] [PubMed] [Google Scholar]
  18. Marx S. J., Attie M. F., Stock J. L., Spiegel A. M., Levine M. A. Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab. 1981 Apr;52(4):736–740. doi: 10.1210/jcem-52-4-736. [DOI] [PubMed] [Google Scholar]
  19. Marx S. J., Sharp M. E., Krudy A., Rosenblatt M., Mallette L. E. Radioimmunoassay for the middle region of human parathyroid hormone: studies with a radioiodinated synthetic peptide. J Clin Endocrinol Metab. 1981 Jul;53(1):76–84. doi: 10.1210/jcem-53-1-76. [DOI] [PubMed] [Google Scholar]
  20. Marx S. J., Spiegel A. M., Brown E. M., Koehler J. O., Gardner D. G., Brennan M. F., Aurbach G. D. Divalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. Am J Med. 1978 Aug;65(2):235–242. doi: 10.1016/0002-9343(78)90814-8. [DOI] [PubMed] [Google Scholar]
  21. Marx S. J., Spiegel A. M., Brown E. M., Windeck R., Gardner D. G., Downs R. W., Jr, Attie M., Aurbach G. D. Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab. 1978 Dec;47(6):1190–1197. doi: 10.1210/jcem-47-6-1190. [DOI] [PubMed] [Google Scholar]
  22. Marx S. J., Spiegel A. M., Sharp M. E., Brown E. M., Gardner D. G., Downs R. W., Jr, Attie M. F., Stock J. L. Adenosine 3',5'-monophosphate response to parathyroid hormone: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab. 1980 Mar;50(3):546–548. doi: 10.1210/jcem-50-3-546. [DOI] [PubMed] [Google Scholar]
  23. Marx S. J., Stock J. L., Attie M. F., Downs R. W., Jr, Gardner D. G., Brown E. M., Spiegel A. M., Doppman J. L., Brennan M. F. Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration. Ann Intern Med. 1980 Mar;92(3):351–356. doi: 10.7326/0003-4819-92-3-351. [DOI] [PubMed] [Google Scholar]
  24. Massry S. G., Coburn J. W., Chapman L. W., Kleeman C. R. Role of serum Ca, parathyroid hormone, and NaCl infusion on renal Ca and Na clearances. Am J Physiol. 1968 Jun;214(6):1403–1409. doi: 10.1152/ajplegacy.1968.214.6.1403. [DOI] [PubMed] [Google Scholar]
  25. Means A. R., Dedman J. R. Calmodulin--an intracellular calcium receptor. Nature. 1980 May 8;285(5760):73–77. doi: 10.1038/285073a0. [DOI] [PubMed] [Google Scholar]
  26. Parfitt A. M. The spectrum of hypoparathyroidism. J Clin Endocrinol Metab. 1972 Jan;34(1):152–158. doi: 10.1210/jcem-34-1-152. [DOI] [PubMed] [Google Scholar]
  27. Paterson C. R., Gunn A. Familial benign hypercalcaemia. Lancet. 1981 Jul 11;2(8237):61–63. doi: 10.1016/s0140-6736(81)90410-4. [DOI] [PubMed] [Google Scholar]
  28. Peacock M., Robertson W. G., Nordin B. E. Relation between serum and urinary calcium with particular reference to parathyroid activity. Lancet. 1969 Feb 22;1(7591):384–386. doi: 10.1016/s0140-6736(69)91353-1. [DOI] [PubMed] [Google Scholar]
  29. Spiegel A. M., Harrison H. E., Marx S. J., Brown E. M., Aurbach G. D. Neonatal primary hyperparathyroidism with autosomal dominant inheritance. J Pediatr. 1977 Feb;90(2):269–272. doi: 10.1016/s0022-3476(77)80649-5. [DOI] [PubMed] [Google Scholar]
  30. Thompson N. W., Carpenter L. C., Kessler D. L., Nishiyama R. H. Hereditary neonatal hyperparathyroidism. Arch Surg. 1978 Jan;113(1):100–103. doi: 10.1001/archsurg.1978.01370130102020. [DOI] [PubMed] [Google Scholar]
  31. Thorgeirsson U., Costa J., Marx S. J. The parathyroid glands in familial hypocalciuric hypercalcemia. Hum Pathol. 1981 Mar;12(3):229–237. doi: 10.1016/s0046-8177(81)80123-2. [DOI] [PubMed] [Google Scholar]
  32. WALSER M., DAVIDSON D. G., ORLOFF J. The renal clearance of alkali-stable inulin. J Clin Invest. 1955 Oct;34(10):1520–1523. doi: 10.1172/JCI103204. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES